Delivery Order SPE2DB22D1002-SPE2DB24FLHZ8

Award Date 9/18/24
Potential Completion Date 9/19/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the drug Mounjaro (tirzepatide) 5 mg/0.5 ml pen. The $3,156 firm fixed-price delivery order has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,081.35 Firm Fixed Price Delivery Order covers the supply of the medication Mounjaro (Tirzepatide) 10 mg/0.5 ml pen in a 0.5 ml quantity. The contract has an ultimate completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of the medication Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen. The $35,119.82 firm fixed-price delivery order has a period of performance through November 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,090.44 firm fixed-price delivery order is for the medication Mounjaro (tirzepatide) 10 mg/0.5 ml pen with a completion date of May 1, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,681.42 firm fixed-price delivery order is for the supply of the medication Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen, with an ultimate completion date of November 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award from the Defense Logistics Agency (DLA) was issued to the pharmaceutical distribution company Amerisourcebergen Drug Corp (Amerisourcebergen) to provide the drug Mounjaro (tirzepatide) 5 mg/0.5 mL pens. The $1,841.00 firm-fixed-price delivery order has an ultimate completion date of August 20, 2024. Amerisourcebergen is the prime contractor for this contract, which does not have a set-aside designation. This award is likely part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Mounjaro (tirzepatide) 10 mg/0.5 ml pens. The award, valued at $10,221.48, is a delivery order under an Indefinite Delivery Contract (IDC) with a total potential value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,309.69 firm fixed-price delivery order covers the supply of the medication Mounjaro (Tirzepatide) 5 mg/0.5 ml pens. This award is a task order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which provides a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Mounjaro (tirzepatide) 5 mg/0.5 ml pens. The $45,378.33 firm fixed-price contract has an ultimate completion date of October 24, 2024. AmerisourceBergen, a for-profit corporate entity registered in the System for Award Management (SAM.gov), has an extensive history of federal contract awards with DLA and other agencies,...
The U.S. Defense Logistics Agency (DLA) awarded a $9,954.88 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of the drug Mounjaro (tirzepatide) 5 mg/0.5 mL pens. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FLHZ8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the drug Mounjaro (tirzepatide) 15 mg/0.5 ml pen. The $3,897.84 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a wide range of medical commodities to support military healthcare programs. The contract has a completion date of September 19, 2024 and does not have a set-aside designation. As a significant supplier of pharmaceutical products and medical supplies to the U.S. federal government, AmerisourceBergen leverages its extensive distribution network to deliver essential medications and medical equipment to various defense and civilian agencies.

Generated 12/18/24, 9:20 AM